| Year |
Title |
Altmetric |
| 2023
|
Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified..
Catheterization and Cardiovascular Interventions.
2023
|
|
| 2023
|
Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach.
PLoS One.
18.
2023
|
|
| 2023
|
Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative.
PLoS One.
18.
2023
|
|
| 2023
|
Higher hospitalization and mortality rates among SARS-CoV-2-infected persons in rural America.
Journal of Rural Health.
39:39-54.
2023
|
|
| 2023
|
Lower-extremity symptoms and ankle–brachial index screening as predictors of cardiovascular outcomes in Black adults
2023
|
|
| 2022
|
Drug-coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years.
Catheterization and Cardiovascular Interventions.
100:1284-1285.
2022
|
|
| 2022
|
Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
Catheterization and Cardiovascular Interventions.
100:747-748.
2022
|
|
| 2022
|
Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults.
Journal of the American Heart Association.
11.
2022
|
|
| 2022
|
Microwave Ablation for Malignant Central Airway Obstruction: A Pilot Study
2022
|
|
| 2022
|
Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
Catheterization and Cardiovascular Interventions.
100:83-84.
2022
|
|
| 2022
|
Social determinants of trauma care: Associations of race, insurance status, and place on opioid prescriptions, postdischarge referrals, and mortality.
Journal of Trauma and Acute Care Surgery.
92:897-905.
2022
|
|
| 2022
|
Brain injury in preterm infants with surgical necrotizing enterocolitis: clinical and bowel pathological correlates.
Pediatric Research.
91:1182-1195.
2022
|
|
| 2022
|
Successfully treating the common femoral artery “no go zone” with directional atherectomy plus antirestenotic therapy (DAART).
Catheterization and Cardiovascular Interventions.
99:1317-1318.
2022
|
|
| 2022
|
Antihypertensive effects of immunosuppressive therapy in autoimmune disease.
Journal of Human Hypertension.
2022
|
|
| 2022
|
Clinical and histopathological correlates of intestinal repair in preterm infants following surgical necrotizing enterocolitis
2022
|
|
| 2022
|
Clinical impact of severe acute kidney injury on post-operative and brain injury outcomes in preterm infants following surgical necrotizing enterocolitis
2022
|
|
| 2022
|
Clinical outcomes and gestational age based prediction of pneumatosis intestinalis in preterm infants with necrotizing enterocolitis.
Journal of Neonatal-Perinatal Medicine.
15:803-812.
2022
|
|
| 2022
|
Racial, Gender, and Neighborhood-Level Disparities in Pediatric Trauma Care.
Journal of Racial and Ethnic Health Disparities.
2022
|
|
| 2021
|
Characterizing Long COVID: Deep Phenotype of a Complex Condition.
EBioMedicine.
74.
2021
|
|
| 2021
|
The Association Between Neighborhood Social Vulnerability and COVID-19 Testing, Positivity, and Incidence in Alabama and Louisiana.
Journal of Community Health.
46:1115-1123.
2021
|
|
| 2021
|
Covered stents favored in complex aortoiliac disease.
Catheterization and Cardiovascular Interventions.
98:938-939.
2021
|
|
| 2021
|
Diabetes and everolimus eluting bioresorbable poly-L-lactide vascular scaffolds for coronary artery disease: Dead-end or some path forward?.
Catheterization and Cardiovascular Interventions.
98:721-722.
2021
|
|
| 2021
|
Systemic toxicities of trastuzumab-emtansine predict tumor response in HER2+ metastatic breast cancer.
International Journal of Cancer.
149:909-916.
2021
|
|
| 2021
|
Critical limb ischemia in the end stage renal disease patient: Some next steps.
Catheterization and Cardiovascular Interventions.
98:308-309.
2021
|
|
| 2021
|
A New Method to Optimize Stent Deployment by High-Definition Intravascular Ultrasound
2021
|
|
| 2021
|
Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?.
Catheterization and Cardiovascular Interventions.
97:795-796.
2021
|
|
| 2021
|
Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.
Catheterization and Cardiovascular Interventions.
97:579-580.
2021
|
|
| 2021
|
Everolimus eluting bioresorbable vascular scaffolds for infrapopliteal critical limb ischemia: Moving beyond grasping at metal straws.
Catheterization and Cardiovascular Interventions.
97:150-151.
2021
|
|
| 2020
|
Ticagrelor monotherapy: When is mono-antiplatelet therapy (MAPT) equivalent or better?.
Catheterization and Cardiovascular Interventions.
96:1379-1380.
2020
|
|
| 2020
|
Radial access and risk guided use of bivalirudin?.
Catheterization and Cardiovascular Interventions.
96:1249-1250.
2020
|
|
| 2020
|
Safety and efficacy of paclitaxel drug-coated balloon treatment of femoropopliteal claudicants: Data and analytic methods matter.
Catheterization and Cardiovascular Interventions.
96:1100-1101.
2020
|
|
| 2020
|
Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
Hypertension.
76:1600-1607.
2020
|
|
| 2020
|
A step toward physiologically guided chronic limb-threatening ischemia intervention.
Catheterization and Cardiovascular Interventions.
96:913-914.
2020
|
|
| 2020
|
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data
2020
|
|
| 2020
|
Insulin-treated diabetes mellitus: An actionable risk factor and marker after percutaneous coronary intervention.
Catheterization and Cardiovascular Interventions.
96:309-310.
2020
|
|
| 2020
|
A step forward in predicting anterograde crossing success for infrapopliteal chronic total occlusions.
Catheterization and Cardiovascular Interventions.
95:756-757.
2020
|
|
| 2020
|
Prior probability of significant obstructive arterial disease in the contralateral lower extremity.
Catheterization and Cardiovascular Interventions.
95:307-308.
2020
|
|
| 2019
|
Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention.
Journal of the American Heart Association.
8.
2019
|
|
| 2019
|
Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
Catheterization and Cardiovascular Interventions.
94:818-819.
2019
|
|
| 2019
|
Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.
Catheterization and Cardiovascular Interventions.
93:1137.
2019
|
|
| 2019
|
Intravascular ultrasound of normal left main arteries: Insights for stent optimization and standardization.
Catheterization and Cardiovascular Interventions.
93:239-240.
2019
|
|
| 2018
|
Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta-analysis?.
Catheterization and Cardiovascular Interventions.
92:1161-1162.
2018
|
|
| 2018
|
“Expanding the frame” for valve-in-valve therapy in small bioprostheses: Encouraging signs for the road ahead.
Catheterization and Cardiovascular Interventions.
92:555-556.
2018
|
|
| 2018
|
Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
Catheterization and Cardiovascular Interventions.
92:431-432.
2018
|
|
| 2018
|
Patent foramen ovale closure for cryptogenic stroke: Effective, but only in select patients.
Catheterization and Cardiovascular Interventions.
92:174-175.
2018
|
|
| 2018
|
Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.
Catheterization and Cardiovascular Interventions.
91:696.
2018
|
|
| 2018
|
The promise of effective P2Y12 platelet receptor pretreatment: Not crushed yet.
Catheterization and Cardiovascular Interventions.
91:251-252.
2018
|
|
| 2018
|
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
JACC: Cardiovascular Interventions.
11:181-191.
2018
|
|
| 2018
|
Patient preference: An important emerging factor in operator access site selection.
Catheterization and Cardiovascular Interventions.
91:25-26.
2018
|
|
| 2017
|
Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.
Clinical Pharmacology and Therapeutics.
102:493-501.
2017
|
|
| 2017
|
Individualizing dual antiplatelet therapy duration: Prediction tools, genomics, and clinical judgment.
Catheterization and Cardiovascular Interventions.
90:38.
2017
|
|
| 2017
|
Length and pressure matter: Expediting evidence-based progress in femoropoliteal intervention.
Catheterization and Cardiovascular Interventions.
89:1257-1258.
2017
|
|
| 2017
|
The many radial access learning curves.
Catheterization and Cardiovascular Interventions.
89:865-866.
2017
|
|
| 2017
|
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
Journal of the American College of Cardiology.
69:395-403.
2017
|
|
| 2017
|
Anticoagulation control in patients with ventricular assist devices.
ASAIO Journal.
63:759-765.
2017
|
|
| 2017
|
Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
Catheterization and Cardiovascular Interventions.
89:11-12.
2017
|
|
| 2016
|
Radial Access Optimization in the Nascent Post-Adoption Era.
Catheterization and Cardiovascular Interventions.
88:1044-1045.
2016
|
|
| 2016
|
Routine invasive evaluation in non ST elevation myocardial infarction (NSTEMI-ACS): Optimizing best.
Catheterization and Cardiovascular Interventions.
88:775-776.
2016
|
|
| 2016
|
End of the bare metal stent era?.
Catheterization and Cardiovascular Interventions.
88:49-50.
2016
|
|
| 2016
|
Valvular Heart disease and acquired type 2A von willebrand syndrome: The "hemostatic" waring blender syndrome.
JAMA Cardiology.
1:205-206.
2016
|
|
| 2016
|
Risk-guided use of the direct thrombin inhibitor bivalirudin.
Catheterization and Cardiovascular Interventions.
87:401-402.
2016
|
|
| 2016
|
Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.
Catheterization and Cardiovascular Interventions.
87:63-64.
2016
|
|
| 2016
|
Risk guided use of the direct thrombin inhibitor bivalirudin: Insights from recent trials and analyses.
Journal of Thoracic Disease.
8:E1034-E1040.
2016
|
|
| 2015
|
Diabetes is not sufficient justification for IIb/IIIa use in percutaneous coronary intervention.
Catheterization and Cardiovascular Interventions.
86:376-377.
2015
|
|
| 2015
|
Renal artery stenting: Patient selection post-CORAL.
Catheterization and Cardiovascular Interventions.
86:310-311.
2015
|
|
| 2015
|
Obesity and percutaneous coronary intervention outcomes: Beware the extremes.
Catheterization and Cardiovascular Interventions.
85:959-960.
2015
|
|
| 2015
|
Percutaneous coronary intervention: Ever closer to real world silver bullets!?.
Catheterization and Cardiovascular Interventions.
85:807-808.
2015
|
|
| 2015
|
Can femoral access bleeding outcomes be improved?.
Catheterization and Cardiovascular Interventions.
85:380-381.
2015
|
|
| 2015
|
Optimal DAPT duration: Each in their own time.
Catheterization and Cardiovascular Interventions.
85:41-42.
2015
|
|
| 2015
|
Response to letter regarding article, "the learning curve for transradial percutaneous coronary intervention among operators in the United States: A study from the national cardiovascular data registry".
Circulation.
131:e358.
2015
|
|
| 2015
|
Sex, prescribing practices and guideline recommended, blood pressure, and LDL cholesterol targets at baseline in the BARI 2D trial.
International Journal of Endocrinology.
2015.
2015
|
|
| 2014
|
The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
Postgraduate Medical Journal.
90:722-729.
2014
|
|
| 2014
|
The learning curve for transradial percutaneous coronary intervention among operators in the united states: A study from the national cardiovascular data registry.
Circulation.
129:2277-2286.
2014
|
|
| 2014
|
The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
Annals of the Rheumatic Diseases.
73:1301-1308.
2014
|
|
| 2013
|
Thromboaspiration and IIb/IIIa therapy in STEMI: Abciximab redux?.
Catheterization and Cardiovascular Interventions.
82:612-613.
2013
|
|
| 2013
|
Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention an updated report from the national cardiovascular data registry (2007-2012).
Circulation.
127:2295-2306.
2013
|
|
| 2013
|
Stent paleology: Diabetic lessons from extinct stents.
Catheterization and Cardiovascular Interventions.
81:1125-1126.
2013
|
|
| 2013
|
Diabetes and everolimus-eluting stents: Good offense scores but defense wins tough games.
Catheterization and Cardiovascular Interventions.
81:766-767.
2013
|
|
| 2012
|
Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: A report from the national cardiovascular data registry, 2004 to 2008.
Journal of the American College of Cardiology.
60:2280-2289.
2012
|
|
| 2012
|
Saphenous vein grafts: Two substrates, two treatments?.
Catheterization and Cardiovascular Interventions.
80:1137.
2012
|
|
| 2012
|
Benefit of renal artery stenting: Is on-target therapy the observational bias?.
Catheterization and Cardiovascular Interventions.
80:351.
2012
|
|
| 2012
|
ACP Journal Club: 24- and 6-month dual antiplatelet therapy after coronary stenting did not differ for clinical outcomes..
ACP journal club.
157:JC2-JC9.
2012
|
|
| 2012
|
Commentary.
Annals of Internal Medicine.
157.
2012
|
|
| 2012
|
Rotational atherectomy for heavily calcified unprotected left main disease: Proceed with caution.
Catheterization and Cardiovascular Interventions.
80:221.
2012
|
|
| 2012
|
Implicit rationing of percutaneous coronary intervention: The left main test case.
Catheterization and Cardiovascular Interventions.
79:1117.
2012
|
|
| 2012
|
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: A report from the national cardiovascular data registry, 2004 to 2008.
Journal of the American College of Cardiology.
59:648-654.
2012
|
|
| 2011
|
Diabetes and percutaneous coronary intervention drug-eluting: Stents whenever feasible.
Catheterization and Cardiovascular Interventions.
78:718-719.
2011
|
|
| 2011
|
Quality assessment and improvement in interventional cardiology: A position statement of the society of cardiovascular angiography and interventions, Part II: Public reporting and risk adjustment.
Catheterization and Cardiovascular Interventions.
78:493-502.
2011
|
|
| 2011
|
Shock and age: The role of an early invasive strategy.
Catheterization and Cardiovascular Interventions.
78:512-513.
2011
|
|
| 2011
|
Quality assessment and improvement in interventional cardiology: A position statement of the Society of Cardiovascular Angiography and Interventions, part 1: Standards for quality assessment and improvement in interventional cardiology.
Catheterization and Cardiovascular Interventions.
77:927-935.
2011
|
|
| 2011
|
A full toolbox fixes the roadblocks.
Catheterization and Cardiovascular Interventions.
77:759-760.
2011
|
|
| 2011
|
ACP Journal Club. Review: Third-generation P2Y12 inhibitors reduce mortality after PCI more than clopidogrel..
ACP journal club.
154:JC3-JC6.
2011
|
|
| 2011
|
DES in SVGs: Safe and at least short-term effective.
Catheterization and Cardiovascular Interventions.
77:356-357.
2011
|
|
| 2011
|
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: An overview.
Vascular Health and Risk Management.
7:445-459.
2011
|
|
| 2010
|
High glycemic stenting menu.
Catheterization and Cardiovascular Interventions.
76:934-935.
2010
|
|
| 2010
|
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the bypass angioplasty revascularization investigation 2 diabetes trial.
Circulation.
122:1690-1699.
2010
|
|
| 2010
|
Drug-eluting or bare metal stents for diabetics: Clinical judgment still wins.
Catheterization and Cardiovascular Interventions.
76:482-483.
2010
|
|
| 2010
|
The holy grail for DES: Does efficacy translate into real world effectiveness?.
Catheterization and Cardiovascular Interventions.
76:381-382.
2010
|
|
| 2010
|
Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?.
Catheterization and Cardiovascular Interventions.
76:58-59.
2010
|
|
| 2010
|
Bifurcation stenting: A commitment to always kiss.
Catheterization and Cardiovascular Interventions.
75:614-615.
2010
|
|
| 2010
|
The effect of obesity on quality of life in patients with diabetes and coronary artery disease.
American Heart Journal.
159:292-300.
2010
|
|
| 2009
|
Treatment of Refractory Iatrogenic Femoral Artery Pseudoaneurysm with a Vascular Closure Device
2009
|
|
| 2009
|
As goes the access, so goes the intervention?.
Catheterization and Cardiovascular Interventions.
74:932-933.
2009
|
|
| 2009
|
The modern axis of peri-procedural evil.
Catheterization and Cardiovascular Interventions.
74:56-57.
2009
|
|
| 2009
|
ACP Journal Club. Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI..
ACP journal club.
150:JC6-J10.
2009
|
|
| 2009
|
Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI: Commentary.
Annals of Internal Medicine.
150.
2009
|
|
| 2009
|
Multivessel disease in diabetics: Does DES level the field?.
Catheterization and Cardiovascular Interventions.
73:881-882.
2009
|
|
| 2009
|
A third dimension to uncloud the funnel plot of operator quality.
Catheterization and Cardiovascular Interventions.
73:595-596.
2009
|
|
| 2009
|
Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions
2009
|
|
| 2009
|
Clinical Significance of Post-Procedural TIMI Flow in Patients With Cardiogenic Shock Undergoing Primary Percutaneous Coronary Intervention.
JACC: Cardiovascular Interventions.
2:56-64.
2009
|
|
| 2009
|
Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions..
Catheterization and Cardiovascular Interventions.
74:1096.
2009
|
|
| 2008
|
Native vessel PCI in the diabetic: DES whenever feasible.
Catheterization and Cardiovascular Interventions.
72:608-609.
2008
|
|
| 2008
|
Vascular changes and black hole phenomenon after coronary brachytherapy: A pathologically distinct entity
2008
|
|
| 2008
|
Prasugrel reduced ischemic outcomes more than did clopidogrel in patients receiving stents for ACS..
ACP journal club.
149:12.
2008
|
|
| 2008
|
The bone marrow and endovascular therapy.
Catheterization and Cardiovascular Interventions.
72:210-211.
2008
|
|
| 2008
|
DES in saphenous bypass grafts: A treatment in vain?.
Catheterization and Cardiovascular Interventions.
72:21-22.
2008
|
|
| 2008
|
Review: late percutaneous coronary intervention after AMI improves survival more than optimal medical therapy..
ACP journal club.
149:6.
2008
|
|
| 2007
|
Ruptured giant right coronary artery aneurysm percutaneously plugged
2007
|
|
| 2007
|
Aspirin was cost-effective for primary prevention of cardiovascular events in older women at moderate risk..
ACP journal club.
147:24.
2007
|
|
| 2007
|
First human case description of TandemHeart™-assisted high-risk percutaneous balloon aortic valvuloplasty using bivalirudin anticoagulation
2007
|
|
| 2007
|
Urgent revascularization with PCI was more cost-effective than CABG in medically refractory, high-risk myocardial ischemia..
ACP journal club.
146:49.
2007
|
|
| 2006
|
Severe, diffuse coronary artery spasm after drug-eluting stent placement
2006
|
|
| 2006
|
Prophylactic implantable cardioverter-defibrillators increased life expectancy with an acceptable cost-effectiveness ratio..
ACP journal club.
144:52.
2006
|
|
| 2006
|
Rescue angioplasty reduced cardiovascular and cerebrovascular outcomes in acute MI after failed thrombolytic therapy..
ACP journal club.
144:60-61.
2006
|
|
| 2006
|
Review: evidence supporting reduced death and reinfarction by percutaneous coronary intervention after thrombolysis is inconclusive..
ACP journal club.
144:60-61.
2006
|
|
| 2005
|
Commentary.
Evidence-based Cardiovascular Medicine.
9:70-71.
2005
|
|
| 2005
|
Cypher drug-eluting stent treatment of tibioperoneal obstructive disease: A case report.
Catheterization and Cardiovascular Interventions.
64:237-241.
2005
|
|
| 2005
|
Invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reinfarction, and ischemia-induced revascularization in STEMI..
ACP journal club.
142:38.
2005
|
|
| 2004
|
Results of intracoronary β-brachytherapy administered by 60 mm transfer device/radiation source train: A subgroup analysis from the RENO registry
2004
|
|
| 2004
|
Long-Term Follow-Up of Brachytherapy for Treatment of Allograft In-Stent Restenosis.
Catheterization and Cardiovascular Interventions.
61:217-221.
2004
|
|
| 2004
|
High-dose atorvastatin was superior to standard-dose pravastatin for reducing death or major cardiovascular events in acute coronary syndromes..
ACP journal club.
141:33.
2004
|
|
| 2003
|
Treatment of In-Stent Restenosis in a Gastroepiploic Artery Coronary Bypass Graft with Brachytherapy
2003
|
|
| 2003
|
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: Observations from the ESPRIT trial.
Journal of the American College of Cardiology.
41:386-393.
2003
|
|
| 2003
|
An early invasive strategy reduced death, myocardial infarction, and hospital readmissions at 2 years in unstable CAD..
ACP journal club.
139:30.
2003
|
|
| 2003
|
An interventional strategy was better than a conservative strategy in unstable angina or non-ST-elevation MI..
ACP journal club.
138:32.
2003
|
|
| 2003
|
Review: low-molecular-weight heparin is effective and safe in the acute coronary syndromes..
ACP journal club.
139:58.
2003
|
|
| 2002
|
How best to use GP IIb/IIIa receptor inhibitors in suspected acute coronary syndromes targeting high-risk patients.
The Journal of critical illness.
17:464-466.
2002
|
|
| 2002
|
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): A randomised trial
2002
|
|
| 2002
|
Cardiac resynchronization was effective for moderate-to-severe heart failure with intraventricular conduction delay..
ACP journal club.
137:82.
2002
|
|
| 2002
|
Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications.
American Heart Journal.
144:501-507.
2002
|
|
| 2001
|
Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An angiographic trials pool data experience.
Journal of the American College of Cardiology.
38:624-630.
2001
|
|
| 2001
|
Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: Initial human clinical experience.
Journal of the American College of Cardiology.
37:1335-1343.
2001
|
|
| 2001
|
Glycoprotein IIb/IIIa receptor therapy in percutaneous coronary intervention and non-ST-segment elevation acute coronary syndromes: Estimating the economic implications
2001
|
|
| 1999
|
Economic issues in glycoprotein IIb/IIIa receptor therapy.
American Heart Journal.
138.
1999
|
|
| 1998
|
Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: Results of the platelet aggregation receptor antagonist dose investigation and reperfusion gain in myocardial infarction (PARADIGM) trial.
Journal of the American College of Cardiology.
32:2003-2010.
1998
|
|
| 1998
|
Abciximab therapy in percutaneous intervention: economic issues in the United States..
European Heart Journal.
19 Suppl D:D52-D58.
1998
|
|
| 1998
|
Abciximab therapy in percutaneous intervention: economic issues in the United States..
American Heart Journal.
135:S90-S97.
1998
|
|
| 1998
|
Stent procedure complicated by thrombus formation distal to the lesion within a muscle bridge.
Catheterization and Cardiovascular Interventions.
43:73-76.
1998
|
|
| 1996
|
Relation between activated clotting time during angioplasty and abrupt closure.
Circulation.
93:667-671.
1996
|
|
| 1996
|
The Economics of IIb/IIIa Therapy.
1996
|
|
| 1996
|
Use of calcium channel antagonists in myocardial revascularization procedures.
American Journal of Cardiology.
77:26D-31D.
1996
|
|
| 1994
|
A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty.
American Journal of Cardiology.
73:835-839.
1994
|
|
| 1994
|
Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction.
American Journal of Cardiology.
73:444-449.
1994
|
|
| 1992
|
Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men.
American Journal of Cardiology.
70:1051-1055.
1992
|
|
